MedPath

Comparison of Changes in Heart Rate following Reversal of Muscle Relaxation by Two Combination :Atropine Plus Neosigmine or Glycopyrrolate Plus Neostigmi

Phase 2
Conditions
Cataract.
Senile Cataract
Registration Number
IRCT2015021019470N16
Lead Sponsor
Vice Chancellor for Research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

patient between 50-70 year old, ASA physical status I, undergoing cataract surgery under general anesthesia with endotracheal tube or laryngeal mask.
Exclusion criteria: Patients with electrolyte abnormalities, cardiovascular problems and using the drugs that affect heart rate and also patients with difficult intubation were excluded from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart Rate. Timepoint: 1) before induction of anesthesia .2) after administration of anesthetic drugs and before drug reversal of muscle relaxation 3) Three minutes after reversal of neuromuscular blockade. 4) ten minutes after reversal of neuromuscular blockade. Method of measurement: EKG.;Arrhythmia. Timepoint: 1) before induction of anesthesia .2) after administration of anesthetic drugs and before drug reversal of muscle relaxation 3) Three minutes after reversal of neuromuscular blockade. 4) ten minutes after reversal of neuromuscular blockade. Method of measurement: EKG.;Blood Pressure. Timepoint: 1) before induction of anesthesia .2) after administration of anesthetic drugs and before drug reversal of muscle relaxation 3) Three minutes after reversal of neuromuscular blockade. 4) ten minutes after reversal of neuromuscular blockade. Method of measurement: Measuring the blood pressure.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath